{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:29Z","timestamp":1786997909108,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vaccine.2024.06.033","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:01:41Z","timestamp":1718323301000},"page":"126066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and-mouth disease virus challenge after vaccination"],"prefix":"10.1016","volume":"42","author":[{"given":"Nancy","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eschbaumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Victoria","family":"Capozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.033_b0005","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1099\/jgv.0.000911","article-title":"ICTV virus taxonomy profile: picornaviridae","volume":"98","author":"Zell","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.06.033_b0010","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.033_b0015","doi-asserted-by":"crossref","first-page":"1027006","DOI":"10.3389\/fvets.2022.1027006","article-title":"Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination","volume":"9","author":"Gubbins","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2024.06.033_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virol.2018.02.012","article-title":"Systemic antibodies administered by passive immunization prevent generalization of the infection by foot-and-mouth disease virus in cattle after oronasal challenge","volume":"518","author":"Barrionuevo","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.06.033_b0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1099\/0022-1317-73-3-727","article-title":"Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22","volume":"73","author":"Bolwell","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2024.06.033_b0030","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1128\/JVI.01082-15","article-title":"Systemic foot-and-mouth disease vaccination in cattle promotes specific antibody-secreting cells at the respiratory tract and triggers local anamnestic responses upon aerosol infection","volume":"89","author":"Pega","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.06.033_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.vaccine.2013.12.007","article-title":"Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle","volume":"32","author":"Brito","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.033_b0040","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1016\/j.vaccine.2012.09.011","article-title":"Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle","volume":"30","author":"Lavoria","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.033_b0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/vaccines8010080","article-title":"Emergency foot-and-mouth disease vaccines A Malaysia 97 and A22 Iraq 64 offer good protection against heterologous challenge with A variant serotype A ASIA\/G-IX\/SEA-97 lineage virus","volume":"8","author":"Singanallur","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.033_b0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.vetmic.2012.10.035","article-title":"Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region","volume":"162","author":"Maradei","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.06.033_b0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0264-410X(96)00284-8","article-title":"Total and isotype humoral responses in cattle vaccinated with foot and mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures","volume":"15","author":"Capozzo","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.033_b0060","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/v14081781","article-title":"Assessment on different vaccine formulation parameters in the protection against heterologous challenge with FMDV in cattle","volume":"14","author":"Di Giacomo","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.06.033_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-5877(00)00115-X","article-title":"Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests","volume":"45","author":"Greiner","year":"2000","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2024.06.033_b0070","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","article-title":"ROCR: visualizing classifier performance in R","volume":"21","author":"Sing","year":"2005","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.vaccine.2024.06.033_b0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Medica"},{"key":"10.1016\/j.vaccine.2024.06.033_b0080","doi-asserted-by":"crossref","first-page":"1033276","DOI":"10.3389\/fvets.2022.1033276","article-title":"Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus","volume":"9","author":"Summerfield","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2024.06.033_b0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cvfa.2019.08.003","article-title":"Mycoplasma bovis: interactions with the immune system and failure to generate an effective immune response","volume":"35","author":"Maunsell","year":"2019","journal-title":"Vet Clin North Am Food Anim Pract"},{"key":"10.1016\/j.vaccine.2024.06.033_b0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3168\/jds.S0022-0302(93)77458-5","article-title":"Opsonization of Staphylococcus aureus by bovine immunoglobulin isotypes","volume":"76","author":"Guidry","year":"1993","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.vaccine.2024.06.033_b0095","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3168\/jds.S0022-0302(69)86871-2","article-title":"Bovine Immunoglobulins: a review","volume":"52","author":"Butler","year":"1969","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.vaccine.2024.06.033_b0100","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1016\/j.vaccine.2014.06.056","article-title":"Influence of antibodies transferred by colostrum in the immune responses of calves to current foot-and-mouth disease vaccines","volume":"32","author":"Bucafusco","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.033_b0105","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/j.vaccine.2011.05.078","article-title":"Foot and mouth disease (FMD) virus: quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography","volume":"29","author":"Spitteler","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.033_b0110","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s00253-019-09680-8","article-title":"Development and validation of a competitive ELISA based on bacterium-original virus-like particles of serotype O foot-and-mouth disease virus for detecting serum antibodies","volume":"103","author":"Ran","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2024.06.033_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114406","article-title":"Development of a competitive ELISA method based on VLPs detecting the antibodies of serotype A FMDV","volume":"300","author":"Zhang","year":"2022","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2024.06.033_b0120","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1016\/j.vaccine.2019.07.102","article-title":"Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory","volume":"37","author":"Paton","year":"2019","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T14:54:55Z","timestamp":1726152895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0264410X24007072"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and-mouth disease virus challenge after vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126066"}}